Novanta Inc. Common Stock (NOVT) is a publicly traded Technology sector company. As of November 9, 2026, NOVT trades at $140.46 with a market cap of $5.11B and a P/E ratio of 101.62. NOVT moved +8.00% today. Year to date, NOVT is +31.55%; over the trailing twelve months it is +38.65%. Its 52-week range spans $98.27 to $176.38. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces NOVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Novanta Q3 net income falls 81% as revenue rises 23% to $305 million: Novanta’s third-quarter net income fell 81% year over year to $2.02 million, while revenue rose 23% to $305 million and adjusted EPS increased 21% to $1.05, above estimates. Riverpoint Medical, its largest-ever acquisition, contributed $32.9 million to revenue growth; the company forecasts 2026 revenue of $1.135 billion to $1.14 billion.
| Metric | Value |
|---|---|
| Price | $140.46 |
| Market Cap | $5.11B |
| P/E Ratio | 101.62 |
| EPS | $1.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $176.38 |
| 52-Week Low | $98.27 |
| Volume | 306.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $980.60M |
| Net Income | $53.83M |
| Gross Margin | 44.39% |
1 analysts cover NOVT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.